Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 10577 - 10584 of 11616 results
"Directly or Indirectly" Means Just That ....
July 26, 2013| Blog| Viewpoint
PCORI Fee Payment and Filing Deadline is July 31, 2013
July 25, 2013| Blog| Viewpoint
EB-5 Funding: A Possible Financing Option for Commercial Ventures Undertaken by Colleges and Universities
July 24, 2013| Blog| Viewpoint
Chinese Investigation of GlaxoSmithKline Broadens as Details Emerge
July 24, 2013| Blog| Viewpoint
Survey Says: Fortune 500 Disclosing Cyber Risks
July 23, 2013| Blog| Viewpoint
Former ArthroCare CEO and CFO Charged with Securities Fraud, Wire Fraud
July 23, 2013| Blog| Viewpoint
The (Best) Method to the Madness Behind Choosing a Company Name or Mark
July 22, 2013| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.